scholarly journals Transfer of Silver Nanoparticles through the Placenta and Breast Milk during in vivo Experiments on Rats

Acta Naturae ◽  
2013 ◽  
Vol 5 (3) ◽  
pp. 107-115 ◽  
Author(s):  
E. A. Melnik ◽  
Yu. P. Buzulukov ◽  
V. F. Demin ◽  
V. A. Demin ◽  
I. V. Gmoshinski ◽  
...  

Silver nanoparticles (NPs), widely used in the manufacture of various types of consumer products and for medical applications, belong to novel types of materials that pose potential risks to human health. The potential negative effects of the influence of these NPs on reproduction are insufficiently researched. A quantitative assessment of the transfer of metallic silver nanoparticles through the placenta and breast milk was carried out during an in vivo experiment. We used 34.9 14.8 nm in size silver NPs that were stabilized by low-molecularweight polyvinylpyrrolidone and labeled with the 110mAg radioactive isotope using thermal neutron irradiation in a nuclear reactor. [110mAg]-labeled NPs preparations were administered intragastrically via a gavage needle to pregnant (20th day of gestation) or lactating (14-16th day of lactation) female rats at a dose of 1.69-2.21 mg/kg of body weight upon conversion into silver. The accumulation of NPs in rat fetuses and infant rats consuming their mothers breast milk was evaluated using a low-background semiconductor gamma-ray spectrometer 24 and 48 hours following labeling, respectively. In all cases, we observed a penetration of the [110mAg]-labeled NPs through the placenta and ther entry into the mothers milk in amounts exceeding by 100-1,000 times the sensitivity of the utilized analytical method. The average level of accumulation of NPs in fetuses was 0.085-0.147% of the administered dose, which was comparable to the accumulation of the label in the liver, blood, and muscle carcass of adult animals and exceeded the penetration of NPs across the hematoencephalic barrier into the brain of females by a factor of 10-100. In lactating females, the total accumulation of [110mAg]-labeled NPs into the milk exceeded 1.94 0.29% of the administered dose over a 48 h period of lactation; not less than 25% of this amount was absorbed into the gastrointestinal tract of infant rats. Thus, this was the first time experimental evidence of the transfer of NPs from mother to offspring through the placenta and breast milk was obtained.

2018 ◽  
Vol 2 (10) ◽  
Author(s):  
Kayla Dean ◽  
Felicia Jefferson

With advances in the development of nanotechnology and increases in the production and practical application of artificial nanoparticles (NPs) and nanomaterials (NMs), health effects of these products are increasingly of interest. Among the most prominent NMs, one variant that has garnered significant attention is silver nanoparticles. Silver nanoparticles (Ag-NPs) are small metallic colloidal particles that are widely used in the engineering, manufacturing, and biomedicine sectors. Today there are many consumer products that contain various silver nanoparticles, particularly for their anti-microbial properties, yet its impact on health has not adequately been evaluated. Early studies show silver nanoparticles contribute to neurotoxic and neurodegenerative effects in vivo. This paper evaluates not only the benefits of silver nanoparticles but the adverse consequences that humans and other organisms may face during extended interaction with silver nanomaterials. Given the particles cross the blood-brain barrier (BBB), specific attention has been placed on the neurological effects of silver nanoparticles. Given the urgency for more information and scientific evaluation on the increasing use of silver nanoparticles, there is still a need for more efficient experimentation methods in the testing of silver nanoparticle toxicity and brain and behavioral effects.


2021 ◽  
Vol 09 ◽  
Author(s):  
Asra Parveen ◽  
Vijay kumar B. Malashetty ◽  
Sushruta Marla ◽  
Shanth Reddy ◽  
Sidramappa Sirsand ◽  
...  

Background: Silver nanoparticles have been widely used in the field of nanomedicine. A comprehensive understanding of their pharmacokinetics is crucial for proper risk assessment and safe biomedical applications. Objectives: The purpose of this study was to investigate the safety of silver nanoparticles by determining its potential toxicity following 28 days administration in Sprague Dawley rats. Method: The silver nanoparticles were administered by intravenous injection at the doses of 100, 200 and 500 µg/kg body weight for 28 consecutive days. Animals in the control group were received sterile water for injection. Each group consists of 10 male and 10 female rats. Results: No treatment related effects were seen in any of the parameters monitored in rats given 100, 200 and 500 µg/kg body weight/day of silver nanoparticles. Conclusion: The study proved that the use of up to 500 µg/kg body weight biosynthesized silver nanoparticles have no toxic effect in the target organs and found safe. However, the safety of the nanoparticles might be attributed to the covering of biological moieties on nanoparticles. Hence, the biofunctionalized nanoparticles can be safely used by selecting the required size and dose in medicines and drug delivery systems.


1988 ◽  
Vol 55 (4) ◽  
pp. 671-683 ◽  
Author(s):  
Chien Chung ◽  
Chih-Ping Chen ◽  
Pao-Shu Chang

2020 ◽  
Vol 17 (Issue 1) ◽  
pp. 54-61
Author(s):  
Mahmoud M. Elalfy ◽  
Mamdouh Abouelmagd ◽  
Eman A. Abdelraheem ◽  
Mona G. El-hadidy

Silver nanoparticles (Ag-NPs) had many uses in medicine, household and industry. To better understand the postnatal toxicity of Ag-NPs in lactating female rats and its offspring’s, 18 female rats after delivery were divided into three groups and dams received orally the AG-NPs at doses of 0, 50, 100 ppm daily for 21 days. After the end of treatment, all rats were euthanized and blood and tissues were separated for evaluation of biochemical and histopathology in dams and its pups. The Ag-NPs had no effect on the dam's weight while the reduction of rats’ pups weight was noticed after first week only after the treatment. Notably, Ag-NPs had toxic effects in rat’s pups, as well as its dam with evidence of elevation of liver enzymes, urea, creatinine and reduction of serum protein, albumin and globulin and considered the first report explained the toxicity in the rat’s pups. Moreover, rats' pups revealed histopathological changes in liver and kidney as well as its dams. Notably, the nano-silver is considered cytotoxic for HepG2 cell line as well as mouse liver cell line. In conclusions, the Ag-NPs considered toxic in offspring as well as dams and had immunosuppressive effects in the postnatal model of toxicity as well as cytotoxicity to hepatic cells lines.


2021 ◽  
Vol 18 (1) ◽  
Author(s):  
Marija Ćurlin ◽  
Rinea Barbir ◽  
Sanja Dabelić ◽  
Marija Ljubojević ◽  
Walter Goessler ◽  
...  

Abstract Background Silver nanoparticles (AgNPs) are widely used in biomedicine due to their strong antimicrobial, antifungal, and antiviral activities. Concerns about their possible negative impacts on human and environmental health directed many researchers towards the assessment of the safety and toxicity of AgNPs in both in vitro and in vivo settings. A growing body of scientific information confirms that the biodistribution of AgNPs and their toxic effects vary depending on the particle size, coating, and dose as well as on the route of administration and duration of exposure. This study aimed to clarify the sex-related differences in the outcomes of oral 28 days repeated dose exposure to AgNPs. Methods Wistar rats of both sexes were gavaged daily using low doses (0.1 and 1 mg Ag/kg b.w.) of polyvinylpyrrolidone (PVP)-coated small-sized (10 nm) AgNPs. After exposure, blood and organs of all rats were analysed through biodistribution and accumulation of Ag, whereas the state of the liver and kidneys was evaluated by the levels of reactive oxygen species (ROS) and glutathione (GSH), catalase (CAT) activity, superoxide dismutase (SOD) and glutathione peroxidase (GPx), expression of metallothionein (Mt) genes and levels of Mt proteins. Results In all animals, changes in oxidative stress markers and blood parameters were observed indicating the toxicity of AgNPs applied orally even at low doses. Sex-related differences were noticed in all assessed parameters. While female rats eliminated AgNPs from the liver and kidneys more efficiently than males when treated with low doses, the opposite was observed for animals treated with higher doses of AgNPs. Female Wistar rats exposed to 1 mg PVP-coated AgNPs/kg b.w. accumulated two to three times more silver in the blood, liver, kidney and hearth than males, while the accumulation in most organs of digestive tract was more than ten times higher compared to males. Oxidative stress responses in the organs of males, except the liver of males treated with high doses, were less intense than in the organs of females. However, both Mt genes and Mt protein expression were significantly reduced after treatment in the liver and kidneys of males, while they remained unchanged in females. Conclusions Observed toxicity effects of AgNPs in Wistar rats revealed sex-related differences in response to an oral 28 days repeated exposure.


2018 ◽  
Vol 2 (08) ◽  
Author(s):  
Kayla Dean ◽  
Felicia Jefferson

With advances in the development of nanotechnology and increases in the production and practical application of artificial nanoparticles (NPs) and nanomaterials (NMs), health effects of these products are increasingly of interest. Among the most prominent NMs, one variant that has garnered significant attention is silver nanoparticles. Silver nanoparticles (Ag-NPs) are small metallic colloidal particles that are widely used in the engineering, manufacturing, and biomedicine sectors. Today there are many consumer products that contain various silver nanoparticles, particularly for their anti-microbial properties, yet its impact on health has not adequately been evaluated. Early studies show silver nanoparticles contribute to neurotoxic and neurodegenerative effects in vivo. This paper evaluates not only the benefits of silver nanoparticles but the adverse consequences that humans and other organisms may face during extended interaction with silver nanomaterials. Given the particles cross the blood-brain barrier (BBB), specific attention has been placed on the neurological effects of silver nanoparticles. Given the urgency for more information and scientific evaluation on the increasing use of silver nanoparticles, there is still a need for more efficient experimentation methods in the testing of silver nanoparticle toxicity and brain and behavioral effects.


Author(s):  
M. Linga Rao ◽  
Bhumi G ◽  
Savithramma N

Silver nanoparticles (SNPs) exhibit tremendous applications in medicine as antimicrobial agent.  The use of different parts of plants for the synthesis of nanoparticles is considered as a green technology as it does not involve any harmful chemicals.  In the present study, we report a rapid biosynthesis of silver nanoparticles from aqueous leaf extract of medicinal plant Allamanda cathartica.  The active phytochemicals present in the plant were responsible for the quick reduction of silver ion to metallic silver nanoparticles. The reduced silver nanoparticles were characterized by using UV-Vis spectrophotometry, Scanning Electron Microscope (SEM), Energy Dispersive Analysis of X-ray (EDAX) and Atomic Force Microscopy (AFM).  The spherical shaped silver nanoparticles were observed and it was found to 19-40 nm range of size.  These phytosynthesized SNPs were tested for their antimicrobial activity and it analyzed by measuring the inhibitory zone. A. cathartica aqueous leaf extract of SNPs showed highest toxicity to Pseudomonas followed by Klebsiella, Bacillus and E. coli and lowest toxicity towards Proteus. In fungal species, highest inhibition zone was noted against Rhizopus followed by Curvularia, Aspergillus flavus and Aspergillus niger and minimum inhibition zone was observed against Fusarium species.  These results suggest a promising potential of Indian plant-based green chemistry for production of SNPs for biomedical and nanotechnology applications.


Sign in / Sign up

Export Citation Format

Share Document